Clinical trial
Tumor-specific Effector T Cells in Non-small Cell Lung Cancer
NCT02515760 is registered in ClinicalTrials.gov with University Hospital Heidelberg as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Tumor-specific Effector T Cells in Non-small Cell Lung Cancer
- Lead sponsor
- University Hospital Heidelberg
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- February 28, 2014
- Completion date
- September 30, 2025
- Enrollment
- 120 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
non-small cell lung cancer